To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
ACON Investments’ BioMatrix is up for sale
The national provider of specialty pharmacy and home infusion services expects to field first-round bids in mid-September.
